Anton Frenkel

This inventor holds 21 USPTO granted patents and 25 published patent applications and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Teva Pharmaceutical Industries Limited, Yeda Research and Develpment & Co. Ltd, Other. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anton Frenkel. Retrieved from https://idiyas.com/inventor/anton-frenkel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 25)

% Patents Active = 19.0

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 255(Granted Patents)

Location History:

Modiin, IL (2001 - 2009)
Netanya, IL (2009 - 2024)

Company Filing History:

18 out of 505

Teva Pharmaceutical Industries Limited

patents

1 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

2 out of 834,570

Other

patents

Years Active: 2001-2024

Loading Chart...

Areas of Expertise:

Escitalopram

Laquinimod

Rasagiline

Propargylated Aminoindans

Polypeptides

Neurodegenerative Diseases

Delayed Release

Crystalline Solids

Amine Salts

Citrate Salt

L-DOPA

Manufacturing Processes

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897858 - Salt and solid state forms of escatalopram (2024-02-13),

2. 11390597 - Salt and solid state forms of escitalopram (2022-07-19),

3. 9346746 - R(+)-N-formyl-propargyl-aminoindan (2016-05-24),

4. 9339469 - R(+)-N-methyl-propargyl-aminoindan (2016-05-17),

5. 9233927 - Crystals of laquinimod sodium and improved process for the manufacture thereof (2016-01-12),

6. 8975279 - Amine salts of laquinimod (2015-03-10),

7. 8673322 - Crystals of laquinimod sodium, and process for the manufacture thereof (2014-03-18),

8. 8647646 - Crystals of laquinimod sodium, and process for the manufacture thereof (2014-02-11),

9. 8614252 - Crystalline solid rasagiline base (2013-12-24),

10. 8334409 - Process for purifying rasagiline base (2012-12-18),

11. 8163960 - Process for preparing and drying solid rasagiline base (2012-04-24),

12. 8080584 - Delayed release rasagiline citrate formulation (2011-12-20),

13. 7968749 - Process for preparing and drying solid rasagiline base (2011-06-28),

14. 7884208 - Crystals of laquinimod sodium, and process for the manufacture thereof (2011-02-08),

15. 7855233 - Citrate salt of Rasagiline (2010-12-21),

Title: Innovator Spotlight - Anton Frenkel: Pioneering Pharmaceuticals

Introduction: Anton Frenkel, a distinguished inventor based in Netanya, Israel, has made significant contributions to the field of pharmaceuticals with a total of 21 patents to his name.

Latest Patents: Among his impressive portfolio, his latest breakthrough includes the development of a new salt and solid state forms of escitalopram. This innovation encompasses processes for preparation, pharmaceutical compositions, and methods of use, representing a significant advancement in the medical industry.

Career Highlights: Anton Frenkel has notably lent his expertise to renowned companies such as Teva Pharmaceutical Industries Limited, a global leader in generic medicines. His role in these institutions has undoubtedly played a pivotal part in shaping the pharmaceutical landscape.

Collaborations: Throughout his career, Frenkel has collaborated with industry peers such as Avital Laxer and Ramy Lidor-Hadas, highlighting his ability to work effectively within multidisciplinary teams to drive innovation forward.

Conclusion: Anton Frenkel's remarkable journey as an inventor showcases his unwavering dedication to pushing the boundaries of pharmaceutical research. His pioneering work continues to leave a lasting impact on the field, setting a high standard for future innovators to aspire to.

Profile summary based on public USPTO records.